Page last updated: 2024-08-18

pyrroles and panobinostat

pyrroles has been researched along with panobinostat in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chandra, J; Corrales-Medina, FF; Manton, CA; Orlowski, RZ1
Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Ryu, Y; Sun, S1
Andreasson, KI; Ceribelli, M; Chen, L; Duveau, DY; Ferrer, M; Geraghty, AC; Ghanem, R; Gillespie, SM; Guha, R; Itkin, Z; Klumpp-Thomas, C; Kreimer, S; Lennon, J; Lin, GL; McKnight, C; Michael, S; Michalowski, AM; Minhas, P; Monje, M; Morris, PJ; Nagaraja, S; Ni, L; Qin, EY; Quezada, M; Raabe, EH; Shinn, P; Stanton, BZ; Thomas, CJ; Vitanza, NA; Warren, KE; Wilson, KM; Woo, PJ; Zhang, X1

Other Studies

3 other study(ies) available for pyrroles and panobinostat

ArticleYear
Efficacy of panobinostat and marizomib in acute myeloid leukemia and bortezomib-resistant models.
    Leukemia research, 2015, Volume: 39, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Caspases; Cell Proliferation; Drug Combinations; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Hydroxamic Acids; Indoles; Lactones; Leukemia, Myeloid, Acute; Panobinostat; Proteasome Inhibitors; Pyrazines; Pyrroles; Tumor Cells, Cultured

2015
Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 101

    Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Gallic Acid; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Hydroxamic Acids; Indoles; Isothiocyanates; Muscle, Smooth, Vascular; Panobinostat; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfoxides

2018
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.
    Science translational medicine, 2019, 11-20, Volume: 11, Issue:519

    Topics: Animals; Brain Neoplasms; Brain Stem Neoplasms; Cell Death; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Synergism; Female; Glioma; High-Throughput Screening Assays; Humans; Lactones; Male; Metabolomics; Mice; Panobinostat; Pyrroles; Reproducibility of Results; Sequence Analysis, RNA; Transcription, Genetic; Xenograft Model Antitumor Assays

2019